SARS CoV-2 Spike Glycoprotein Blocking Peptide for STJ506285 peptide (STJ506287)

SKU:
STJ506287-250

Shipping:
Free Shipping
Current Stock:
Applications: Immunodepletion/Immunocompetition
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: SARS CoV-2 Spike Glycoprotein Blocking Peptide for STJ506285 is synthetically produced from the 450-550 sequence and is suitable for use in western blot applications.
Formulation: Liquid form at 2.5mg/ml concentration in PBS. Up to 5% DMSO can be added. Orders with >1mg can be supplied in lyophilized powder form, or in buffer of choice.
Storage Instruction: Store at-20°C for long term storage. Avoid freeze-thaw cycles.
Immunogen Region: 450-550
Specificity: This blocking peptide is recommended for use in combination with SARS CoV-2 Spike Glycoprotein antibody, STJ506285
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance